Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)

HKG:2185 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	202.39	369.44	451.32	708.53	453.67
Cash & Short-Term Investments	202.39	369.44	451.32	708.53	453.67
Cash Growth	-45.22%	-18.14%	-36.30%	56.18%	2094.60%
Other Receivables	-	6.12	5.8	8.91	2.31
Receivables	-	6.12	5.8	8.91	2.31
Inventory	18.33	3.98	-	-	-
Other Current Assets	78.31	28.93	84.41	39.08	14.78
Total Current Assets	299.03	408.47	541.53	756.53	470.77
Property, Plant & Equipment	51.58	30.91	75.98	72.26	20.27
Long-Term Investments	53.91	87.06	73.23	-	-
Goodwill	144.63	144.63	144.63	144.63	144.63
Other Intangible Assets	137.59	137.71	137.54	137.2	137.2
Long-Term Deferred Charges	-	-	-	-	8.27
Other Long-Term Assets	47.05	9.12	8.61	4.3	3.9
Total Assets	733.78	817.9	981.52	1,115	785.04
Accounts Payable	0.1	-	-	0.01	0.01
Accrued Expenses	13.77	8.6	8.02	9.14	4.7
Current Portion of Leases	1.27	1.58	7.62	7.31	1.24
Current Unearned Revenue	-	3.39	0.96	0.98	0.52
Other Current Liabilities	4.52	6.5	12.25	19.37	7.4
Total Current Liabilities	19.65	20.07	28.85	36.81	13.87
Long-Term Leases	7.01	0.18	10.49	15.14	0.08
Long-Term Unearned Revenue	6	3.21	6.55	7.52	6.6
Long-Term Deferred Tax Liabilities	20.58	20.58	20.58	20.58	20.58
Total Liabilities	53.24	44.04	66.47	80.04	41.13
Common Stock	243.94	243.94	243.94	243.94	220
Additional Paid-In Capital	662.42	662.42	662.42	662.42	304.29
Retained Earnings	-	-	-673.44	-469.21	-107.76
Treasury Stock	-29.44	-29.44	-29.44	-	-
Comprehensive Income & Other	-216.45	-128.51	679.74	558.54	283.55
Total Common Equity	660.47	748.41	883.21	995.69	700.09
Minority Interest	20.07	25.45	31.84	39.19	43.82
Shareholders' Equity	680.53	773.86	915.05	1,035	743.91
Total Liabilities & Equity	733.78	817.9	981.52	1,115	785.04
Total Debt	8.28	1.76	18.11	22.45	1.32
Net Cash (Debt)	194.1	367.68	433.21	686.09	452.35
Net Cash Growth	-47.21%	-15.13%	-36.86%	51.67%	2237.85%
Net Cash Per Share	0.80	1.51	1.78	3.11	3.31
Filing Date Shares Outstanding	243.42	243.42	243.42	243.94	220
Total Common Shares Outstanding	243.42	243.42	243.42	243.94	220
Working Capital	279.38	388.4	512.68	719.72	456.9
Book Value Per Share	2.71	3.07	3.63	4.08	3.18
Tangible Book Value	378.25	466.07	601.04	713.86	418.26
Tangible Book Value Per Share	1.55	1.91	2.47	2.93	1.90
Buildings	20.25	-	-	-	-
Machinery	39.31	53.24	38.66	33.57	29.62
Construction In Progress	-	-	8.16	19.63	-
Leasehold Improvements	22.38	21.82	61.85	31.52	14.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.